The functional roles of chemokines and chemokine receptors in colorectal cancer progression

被引:11
作者
Yue, Mingli [1 ]
Chen, Meng-Meng [3 ,4 ]
Zhang, Bingqiang [3 ]
Wang, Yin [1 ]
Li, Peifeng [1 ]
Zhao, Yi [1 ,2 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Coll Med, Inst Translat Med, Qingdao 266021, Peoples R China
[2] Qingdao Univ, Natl Hlth Commiss China, Maternal & Child Hlth Care Hosp Shandong Prov, Key Lab Birth Regulat & Control Technol, Qingdao, Shandong, Peoples R China
[3] Key Lab Canc & Immune Cells Qingdao, Qingdao 266021, Peoples R China
[4] Qingdao Restore Biotechnol Co Ltd, Qingdao 266111, Shandong, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Chemokines; Chemokines receptors; Tumor microenvironment; Inflammation; Colorectal cancer; EPITHELIAL-MESENCHYMAL TRANSITION; LUNG METASTASIS; KAPPA-B; COLON; CELLS; GROWTH; INFLAMMATION; FIBROBLASTS; RESISTANCE; PROMOTES;
D O I
10.1016/j.biopha.2023.116040
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Colorectal cancer is a common malignancy with significant rates of morbidity and mortality. A number of factors, including the tumor microenvironment, chemokines, the inflammatory response, have an impact on the development of colorectal cancer. A critical component of the tumor microenvironment is chemokines. Various cell subsets are attracted to the tumor microenvironment through interactions with chemokine receptors. These cells have varying effects on the development of the tumor and the effectiveness of treatment. Additionally, chemokines can participate in inflammatory processes and have effects that are either pro- or anti-tumor. Chemokines can be exploited as targets for medication resistance and treatment in colorectal cancer. In this review, we discuss the expression of chemokines and chemokine receptors, and their relationship with immune cells in the tumor microenvironment. At the same time, we also collect and discuss the significance of chemokines and chemokine receptors in colorectal cancer progression, and their potential as molecular targets for CRC treatment.
引用
收藏
页数:10
相关论文
共 108 条
[11]   The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis [J].
Chandra, Raghav ;
Karalis, John D. ;
Liu, Charles ;
Murimwa, Gilbert Z. ;
Voth Park, Josiah ;
Heid, Christopher A. ;
Reznik, Scott I. ;
Huang, Emina ;
Minna, John D. ;
Brekken, Rolf A. .
CANCERS, 2021, 13 (24)
[12]   CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer [J].
Chen, Chun ;
Xu, Zhuo-Qing ;
Zong, Ya-Ping ;
Ou, Bao-Chi ;
Shen, Xiao-Hui ;
Feng, Hao ;
Zheng, Min-Hua ;
Zhao, Jing-Kun ;
Lu, Ai-Guo .
CELL DEATH & DISEASE, 2019, 10 (3)
[13]   Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway [J].
Chen, Ke ;
Liu, Qianqian ;
Tsang, Lai Ling ;
Ye, Qiao ;
Chan, Hsiao Chang ;
Sun, Yunwei ;
Jiang, Xiaohua .
CELL DEATH & DISEASE, 2017, 8 :e2819-e2819
[14]   CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via Gi-2 and Gq/11 [J].
Chen, Ming-Cheng ;
Baskaran, Rathinasamy ;
Lee, Nien-Hung ;
Hsu, Hsi-Hsien ;
Ho, Tsung-Jung ;
Tu, Chuan-Chou ;
Lin, Yueh-Min ;
Viswanadha, Vijaya Padma ;
Kuo, Wei-Wen ;
Huang, Chih-Yang .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) :11822-11834
[15]   Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells [J].
Chen, Ming-Cheng ;
Lee, Nien-Hung ;
Ho, Tsung-Jung ;
Hsu, Hsi-Hsien ;
Kuo, Chia-Hua ;
Kuo, Wei-Wen ;
Lin, Yueh-Min ;
Tsai, Fuu-Jen ;
Tsai, Chang-Hai ;
Huang, Chih-Yang .
CANCER LETTERS, 2014, 349 (01) :51-60
[16]   Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases [J].
Cheng, Yuan ;
Ma, Xue-lei ;
Wei, Yu-quan ;
Wei, Xia-Wei .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1871 (02) :289-312
[17]   Drug therapy: EGFR antagonists in cancer treatment [J].
Ciardiello, Fortunato ;
Tortora, Giampaolo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) :1160-1174
[18]   Clinical management of metastatic colorectal cancer in the era of precision medicine [J].
Ciardiello, Fortunato ;
Ciardiello, Davide ;
Martini, Giulia ;
Napolitano, Stefania ;
Tabernero, Josep ;
Cervantes, Andres .
CA-A CANCER JOURNAL FOR CLINICIANS, 2022, 72 (04) :372-401
[19]   Chemokines - role in inflammatory and cancer diseases [J].
Cison-Jurek, Sylwia ;
Czajka-Francuz, Paulina ;
Francuz, Tomasz ;
Wojnar, Jerzy .
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 :372-386
[20]   Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy [J].
Dama, Paola ;
Tang, Marshall ;
Fulton, Noreen ;
Kline, Justin ;
Liu, Hongtao .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7